COVID-19 Disruption of Trials is in Decline

Published on: 

Applied Clinical Trials

Most disruptions to clinical trials over the past three months were caused by the suspension of enrollment, followed by slow enrollment, and delayed initiation, says GlobalData, a data and analytics company. The number of disrupted trials began to fall between June and July. 

For more information, click here.